Mass spectrometry-based proteomics for translational research: a technical overview

Yale J Biol Med. 2012 Mar;85(1):59-73. Epub 2012 Mar 29.

Abstract

Mass spectrometry-based investigation of clinical samples enables the high-throughput identification of protein biomarkers. We provide an overview of mass spectrometry-based proteomic techniques that are applicable to the investigation of clinical samples. We address sample collection, protein extraction and fractionation, mass spectrometry modalities, and quantitative proteomics. Finally, we examine the limitations and further potential of such technologies. Liquid chromatography fractionation coupled with tandem mass spectrometry is well suited to handle mixtures of hundreds or thousands of proteins. Mass spectrometry-based proteome elucidation can reveal potential biomarkers and aid in the development of hypotheses for downstream investigation of the molecular mechanisms of disease.

Keywords: biomarkers; chronic pancreatitis; mass spectrometry; pancreas.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Chemical Fractionation
  • Humans
  • Mass Spectrometry / methods*
  • Peptides / chemistry
  • Proteomics / methods*
  • Translational Research, Biomedical / methods*

Substances

  • Peptides